BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

Novel Candidate Tuberculosis Treatment Compound Licensing Agreement Between Calibr and Bill & Melinda Gates Medical Research Institute

By

Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced...

FDA Approves First-In-Class HIV Treatment Option

By

Gilead Sciences, Inc. announced this week that Sunlenca® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug Administration (FDA) for the...

FDA Approves Actemra for the Treatment of COVID-19 in Hospitalized Adults

By

NewsDesk @bactiman63 Genentech today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult...

Black-legged tick

Lyme disease: Novel investigative oral therapeutic trials show positive topline results

By

NewsDesk @bactiman63 Tarsus Pharmaceuticals, Inc. announced positive topline results from the completed Phase 1b Callisto trial and the enrollment of the first subject in the Carpo Phase 2a trial. The...

Malaria study: New antimalarial drug, tafenoquine, requires higher doses to achieve cure reliably

By

NewsDesk @bactiman63 A new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a report published in eLife. The study suggests that...

New sleeping sickness drug could be a key in eliminating disease transmission by 2030: Study

By

NewsDesk @bactiman63 A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a new...

MRSA: University of Bath’s novel compound that both inhibits the superbug in lab experiments and renders it more vulnerable to antibiotics

By

NewsDesk @bactiman63 A compound that both inhibits the MRSA superbug and renders it more vulnerable to antibiotics has been discovered by scientists at the University of Bath led by Dr Maisem Laabei and Dr...

U.S. clinical trial for monkeypox antiviral, TPOXX, begins

By

NewsDesk @bactiman63 A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators...

Crimean-Congo hemorrhagic fever: Promising drug candidates identified

By

NewsDesk @bactiman63 Researchers at Karolinska Institutet in Sweden have identified key signalling pathways that when blocked by existing drug candidates limit reproduction of the Crimean-Congo hemorrhagic...

FAU researchers recommend a moratorium on prescribing ivermectin to treat or prevent COVID-19

By

NewsDesk @bactiman63 Ivermectin is a drug approved by the United States Food and Drug Administration (FDA) to treat parasites in animals and in humans with intestinal strongyloidiasis (roundworm) and onchocerciasis (river...